Skip to content

Accumulative Effects of Talus Mobilization

Effects of Anteroposterior Talus Mobilization on Range of Motion, Pain, and Functional Capacity in Participants With Sub-acute and Chronic Ankle Injuries: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02244008
Enrollment
38
Registered
2014-09-18
Start date
2012-07-31
Completion date
2013-12-31
Last updated
2014-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Sprains, Ankle Fractures, Ankle Dislocations, Ankle Bruises, Achilles Tendon Rupture

Keywords

Mobilization, Joint Range of Motion, Ankle, Manual Therapy

Brief summary

The purpose of this study is to verify the effect of anteroposterior talus mobilization on range of motion, pain, and functional capacity in participants with sub-acute and chronic ankle injuries.

Detailed description

The purpose of this study was to verify the acute effect (one session) and chronic (six sessions) and follow-up of the anteroposterior talus mobilization Maitland's grade III on range of motion, pain, and functional capacity in participants with sub-acute and chronic ankle injuries. Thirty eight volunteers subjects (male and female) participated of this study with minimum 18 and maximum 59 years old. The volunteers were allocated in two groups: experimental and control. The variables related to range of motion, pain and functional capacity were measured by biplane goniometer, Visual Analog Scale and Foot and Ankle Ability Measure respectively in four moments: 1- baseline; 2- after the first intervention; 3- after the sixth intervention (two weeks); 4- follow-up (one month). The experimental group received anteroposterior articular mobilization of the talus and the control group received manual contact.

Interventions

The experimental group received joint mobilization (anteroposterior mobilization of the talus - Maitland grade III). During the mobilization cyclic movements were applied in an anteroposterior direction from the first tissue resistance barrier until the end of the accessory range of motion without any pain or discomfort. This mobilization maneuver was performed in 30-second duration sets with a 30-second interval between each set. The interventions lasted two weeks with three sessions each, completing six sessions.

The placebo group received only manual contact. This maneuver was performed in 30-second duration sets with a 30-second interval between each set. The interventions lasted two weeks with three sessions each, completing six sessions.

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* unilateral traumatic injury of the ankle with at least two weeks and maximum eight months * at least a 5º limitation of passive dorsiflexion in comparison to the contralateral side * do not be under another physical therapy treatment for the lesion * able to unload partial or total body weight * do not be in use of analgesic * provided informed consent after receiving and explanation of all procedures and pertinent information regarding the study

Exclusion criteria

* joint blockage by surgical fixation or ankylosis * presence of vascular, rheumatic, neurological and neoplastic disease in the lower limb * open or contagious lesion in the ankle region * pain during palpation in the region anterior of the ankle

Design outcomes

Primary

MeasureTime frameDescription
Changes in dorsiflexion range of motion1 monthDorsiflexion range of motion were measured by biplane goniometer.

Secondary

MeasureTime frameDescription
Changes in pain intensity1 monthPain were measured by Visual Analog Scale.
Changes in functional capacity1 monthFunctional capacity were measured by Foot and Ankle Ability Measure.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026